Diagnosis and management of heparin‐induced thrombocytopenia: Third edition
Deepa J. Arachchillage(Imperial College Healthcare NHS Trust), Michael Laffan(Hammersmith Hospital), Jecko Thachil(University of Manchester), Anthony Poles(NHS Blood and Transplant), Julia A. M. Anderson(Edinburgh Royal Infirmary), Peter Baker(Oxford University Hospitals NHS Trust), Steve Kitchen(Royal Hallamshire Hospital)
Cited by 31
Related Papers
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
|The Lancet Haematology|2016|404
Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders
|Blood|2019|218
Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin gene
|British Journal of Haematology|1997|158